ZCCHC14 divergent transcript (ZCCHC14-DT)

ZCCHC14 divergent transcript (ZCCHC14-DT) is a long non-coding RNA gene located in proximity to the ZCCHC14 coding gene[1][7]. The term "divergent transcript" denotes its transcription from a locus within several hundred nucleotides on the opposite DNA strand near a protein-coding gene, a class described by the HUGO Gene Nomenclature Committee (HGNC)[5]. Such lncRNAs are generated by divergent transcription, a process common at CpG island promoters and enhancers that can give rise to additional non-coding or coding genes[3][5]. However, ZCCHC14-DT itself is currently understood as a non-coding RNA with no well-characterized biological function, disease association, or therapeutic relevance. No direct drug interactions, disease roles, functional annotations, or biomarker status are recorded for this transcript in publicly available resources[1][5][7]. The adjacent protein-coding gene, ZCCHC14 (zinc finger CCHC-type containing 14), has been reported to regulate proliferation and invasion in non-small cell lung cancer, but such functions are not attributed to the divergent transcript ZCCHC14-DT itself[6]. The definition of divergent transcripts confirms they are typically lncRNAs within several hundred nucleotides of a coding gene, often with unclear or subtle biological roles[5][3]. Based on current knowledge, ZCCHC14-DT is a documented lncRNA without established status as a molecular therapeutic target or detailed annotation of its function, interactions, or disease involvement. For structured database entry, most fields should be left as null except for basic identity/classification.